Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

In this publication, the authors explored whether there is a scientific basis for using lymecycline to treat frontal fibrosing alopecia, but the abstract does not provide study results or conclusions on its efficacy.

This study found that topical immunotherapy was effective in 56.83% of pediatric patients with alopecia areata, but those with co-occurring atopic dermatitis were more likely to show an inadequate response to treatment.

This study found that trichoscopy is an effective method for monitoring treatment response in androgenetic alopecia when conducted by doctors experienced in hair diseases, showing excellent agreement with TrichoScan measurements for various hair parameters.

In this study, researchers identified the presence of a "spotted lunula" as a rare sign in patients with alopecia areata, detailing its clinical and onychoscopic features.

This study found that pulse corticosteroids effectively induce hair regrowth in alopecia areata, with betamethasone showing higher efficacy but more side effects, and treatment success varying depending on age, onset time, and disease type.

This study observed that among 120 patients recovering from COVID-19, severe diffuse hair loss typically began less than two months post-infection, with the majority of patients experiencing a severe degree of hair loss and positive hair pull tests, often alongside vitamin D deficiency.

In this case report, folliculitis decalvans with frontal fibrosing alopecia was observed in a patient with a dark phototype, highlighting the phenotypic spectrum of folliculitis decalvans and lichen planopilaris.

Some lung cancer patients treated with EGFR inhibitors may develop a hair loss condition similar to folliculitis decalvans.

This study found that a positive anagen pull test can be an indicator of lichen planopilaris activity, suggesting its utility in the clinical assessment of this condition.

This study concluded that lenalidomide significantly induces the proliferation and migration of melanocyte stem cells, enhancing their differentiation into functional melanocytes in a mouse model.

This study observed that a tacrolimus solution (0.1%) applied to the scalp was effective and well-tolerated for treating inflammatory scalp conditions, with 72.7% of patients showing an excellent response after 2 months of treatment, which persisted after 6 months.

High-dose corticosteroids can significantly regrow hair in severe alopecia areata.

This article addresses the need to screen for nutrient deficiencies in patients with hair loss but reports no new findings, noting that supplementation without deficiency may not be beneficial and could pose risks.

This study reviewed treatments for chemotherapy-induced hair loss, finding that scalp cooling is FDA-approved for prevention, while minoxidil and bimatoprost may aid post-chemotherapy regrowth. The authors emphasized tailored therapies and the potential utility of tools like trichoscopy and trichogram.

This study analyzed the features of alopecia areata incognita and diffuse alopecia areata, finding distinct patterns in hair loss regions and trichoscopic signs, and noted a benign course responsive to topical steroid therapy.

This article reviews the use of laser and light-based devices for hair removal, highlighting their effectiveness in significantly reducing hair growth in individuals with fair skin and dark hair, and suggests that photoepilation offers advantages over traditional hair removal methods.

This study reported that higher monocyte lymphocyte ratio, monocyte high-density lipoprotein cholesterol ratio, and platelet lymphocyte ratio were associated with increased risk of developing alopecia areata, suggesting their potential as diagnostic markers.

This study found that the systemic immune-inflammation index (SII) can be used as a cost-effective marker to assess the severity and treatment response in patients with alopecia areata.

This review discusses the potential risks associated with skin, hair, and nail supplements, highlighting concerns about safety, efficacy, and lack of regulation but reports no new clinical results.

This study reported that among postmenopausal women with female pattern hair loss, treatment with topical finasteride 0.5% and minoxidil 2% was more effective at improving hair condition than treatment with topical 17α-estradiol 0.05% and minoxidil 2%, particularly notable at 12-18 months of follow-up.

This review outlines the practical use of reflectance confocal microscopy in dermatology, detailing its applications and considerations for diagnosing various skin conditions, but reports no new findings.

This study found that trichoscopy is an effective noninvasive technique for diagnosing frontal fibrosing alopecia, confirming its valuable role alongside traditional histopathological examination.

Postmenopausal women can experience hairline recession, affecting their quality of life, and more research is needed for treatments.

This study emphasizes the importance of regular dental check-ups for patients undergoing systemic treatments for psoriatic disease, as it helps prevent oral complications associated with these medications. It recommends collaboration between dermatologists and oral health specialists to effectively manage and communicate these risks.

This study shows that Covid-19 infection significantly impacts the emergence of new-onset hair diseases, with a notable association reported between having Covid-19 and developing hair issues.

In this study, researchers found that women with telogen effluvium had lower MCV/RDW ratios, MPV, and ferritin levels compared to healthy controls, suggesting iron deficiency's involvement in this chronic hair loss condition.

This case report suggests that regular use of antifungal shampoo might obscure clinical indicators of Trichophyton tonsurans tinea capitis in healthy adults, necessitating detailed diagnostic approaches like histopathology and dermoscopy.

This review describes trichoscopy features of lichen planopilaris and frontal fibrosing alopecia, identifying distinct patterns that help differentiate the two conditions.

This study found that iontophoresis combined with growth factors improved hair density and reduced hair loss in patients with androgenetic alopecia and telogen effluvium, with no serious side effects reported.

This review serves as a comprehensive guide to hair pathology with clinical correlations but does not provide new clinical results.